Clear Street’s Sunshine Biopharma Inc Warrant SBFMW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27 Buy
+449
New +$34 ﹤0.01% 1367
2025
Q4
Sell
-94
Closed -$14 994
2025
Q3
$14 Hold
94
﹤0.01% 832
2025
Q2
$27 Hold
94
﹤0.01% 658
2025
Q1
$19 Buy
+94
New +$21 ﹤0.01% 555
2024
Q3
Sell
-1,876
Closed -$131 750
2024
Q2
$131 Hold
1,876
﹤0.01% 733
2024
Q1
$91 Sell
1,876
-200
-10% -$21 ﹤0.01% 738
2023
Q4
$415 Sell
2,076
-100
-5% -$22 ﹤0.01% 703
2023
Q3
$489 Sell
2,176
-200
-8% -$62 ﹤0.01% 950
2023
Q2
$898 Buy
2,376
+400
+20% +$180 ﹤0.01% 1081
2023
Q1
$988 Buy
+1,976
New +$1.03K ﹤0.01% 972
2022
Q2
Sell
-14,126
Closed -$14K 1043
2022
Q1
$14K Buy
+14,126
New +$9.86K ﹤0.01% 236

Other funds holding SBFMW

Clear Street's SBFMW Position: Q2 2026 in Review

Clear Street opened a new position in Sunshine Biopharma Inc Warrant (SBFMW) in Q2 2026: 449 shares worth $27. The stake represents ﹤0.01% of the portfolio and ranks #1367 among its holdings. This is a return to the name: Clear Street previously reported a position in SBFMW as recently as Q3 2025.

Clear Street first reported a position in SBFMW in Q1 2022 and has held it in 11 quarters since. The position peaked at $14K in Q1 2022. 3 funds tracked by Wall St. Rank hold SBFMW as of Q2 2026.

  • Clear Street held 449 shares of Sunshine Biopharma Inc Warrant worth $27 as of Q2 2026.
  • Sunshine Biopharma Inc Warrant was a new Clear Street position in Q2 2026.
  • Sunshine Biopharma Inc Warrant made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #1367 holding.
  • Clear Street first reported a position in Sunshine Biopharma Inc Warrant in Q1 2022 and has held it in 11 quarters since.
  • Clear Street's Sunshine Biopharma Inc Warrant position peaked at $14K in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Sunshine Biopharma Inc Warrant as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.